Senator Cory Gardner has joined the effort to make it easier to conduct scientific research on marijuana as a safe and effective medical treatment. Gardner and Utah Senator Orrin Hatch introduced the Marijuana Effective Drug Study Act of 2017 this week. Gardner says the medical community continues to find new medical uses for marijuana, but currently, there are too many barriers to studying the plant. The legislation will make it easier for universities, hospitals, and scientists to look at new ways that medical marijuana can be used for treatment. Additional information on the impact the Marijuana Effective Drug Study Act could have on medical marijuana research, are available below.
The MEDS Act will:
- Encourage more research on the potential medical uses of marijuana by streamlining the research registration process, without imposing a scheduling determination on the Drug Enforcement Agency (DEA).
- Make marijuana more available for legitimate scientific and medical research and the commercial production of any FDA-approved drugs derived from marijuana.
- Retain important checks to protect against diversion or abuse of the controlled marijuana substances.
- Require the National Institute on Drug Abuse (NIDA) to develop and publish recommendations for good manufacturing practices for growing and producing marijuana for research.
- Require the Attorney General to increase the national marijuana quota in a timely manner to meet the changing medical, scientific, and industrial needs for marijuana.
- Codify the administration’s decision to terminate the Public Health Service and its review of proposals for medical research on marijuana. Prevent the Department of Health and Human Services from instituting any other marijuana-specific protocol reviews, other than the voluntary review that a researcher can request from National Institutes of Health (NIH) in order to access the expedited DEA registration process.